2m 2m 2m 2m 2m 2m 2m
VERRICA PHARMA (VRCA)
NASDAQ
$5.49+$0.27 (+5.11%)
Price as of Aug 03, 2026 10:22 AM EDT- $89.7MMarket Cap
- -7.45%1-Year Change
- BiotechnologyIndustry
VERRICA PHARMA (VRCA)
$5.49+$0.27 (+5.11%)
VRCA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.22 | ||
Change | -$0.04 (-0.76%) | ||
Open | $5.27 | ||
High | $5.55 | ||
Low | $5.21 | ||
Previous Close | $5.26 | ||
Volume | 5,043 | ||
30-Day Average Volume | 29,323 | ||
1-Week Change | 3.98% | ||
1-Month Change | -14.71% | ||
1-Year Change | -7.45% | ||
3-Year Change | -91.06% | ||
5-Year Change | -95.12% | ||
Fundamentals | |||
Shares Outstanding | 17.2M | ||
Total Assets | $38.8M | ||
Market Cap | $89.7M | ||
Enterprise Value | $119.1M | ||
Period: QTR TTM FY | |||
Revenue | $4.3M | ||
Net Income | -$9.7M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$7.5M | ||
EBITDA | -$7.5M | ||
Net Working Capital | $17.9M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 28 | ||
P/B | 6 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2025 | ||
Earnings & Revenue